averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ATF2
|
ENSG00000115966.12 | activating transcription factor 2 |
ATF1
|
ENSG00000123268.4 | activating transcription factor 1 |
ATF3
|
ENSG00000162772.12 | activating transcription factor 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ATF2 | hg19_v2_chr2_-_176032843_176032941 | 0.33 | 4.5e-07 | Click! |
ATF3 | hg19_v2_chr1_+_212738676_212738755, hg19_v2_chr1_+_212782012_212782257 | -0.09 | 2.0e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chrX_+_48432892 | 67.55 |
ENST00000376759.3
ENST00000430348.2 |
RBM3
|
RNA binding motif (RNP1, RRM) protein 3 |
chr19_+_1941117 | 50.92 |
ENST00000255641.8
|
CSNK1G2
|
casein kinase 1, gamma 2 |
chr4_+_113558272 | 49.17 |
ENST00000509061.1
ENST00000508577.1 ENST00000513553.1 |
LARP7
|
La ribonucleoprotein domain family, member 7 |
chr8_-_17104356 | 47.85 |
ENST00000361272.4
ENST00000523917.1 |
CNOT7
|
CCR4-NOT transcription complex, subunit 7 |
chr6_+_139456226 | 46.23 |
ENST00000367658.2
|
HECA
|
headcase homolog (Drosophila) |
chrX_+_155110956 | 42.97 |
ENST00000286448.6
ENST00000262640.6 ENST00000460621.1 |
VAMP7
|
vesicle-associated membrane protein 7 |
chr12_-_92539614 | 42.54 |
ENST00000256015.3
|
BTG1
|
B-cell translocation gene 1, anti-proliferative |
chr3_+_38206975 | 38.69 |
ENST00000446845.1
ENST00000311806.3 |
OXSR1
|
oxidative stress responsive 1 |
chr3_-_185655795 | 38.24 |
ENST00000342294.4
ENST00000382191.4 ENST00000453386.2 |
TRA2B
|
transformer 2 beta homolog (Drosophila) |
chr17_-_685559 | 38.15 |
ENST00000301329.6
|
GLOD4
|
glyoxalase domain containing 4 |
chr19_+_50180317 | 37.83 |
ENST00000534465.1
|
PRMT1
|
protein arginine methyltransferase 1 |
chr1_+_26496362 | 35.97 |
ENST00000374266.5
ENST00000270812.5 |
ZNF593
|
zinc finger protein 593 |
chr12_+_108079664 | 35.73 |
ENST00000541166.1
|
PWP1
|
PWP1 homolog (S. cerevisiae) |
chr22_-_39096661 | 35.67 |
ENST00000216039.5
|
JOSD1
|
Josephin domain containing 1 |
chr17_+_27071002 | 35.57 |
ENST00000262395.5
ENST00000422344.1 ENST00000444415.3 ENST00000262396.6 |
TRAF4
|
TNF receptor-associated factor 4 |
chr17_-_685493 | 35.23 |
ENST00000536578.1
ENST00000301328.5 ENST00000576419.1 |
GLOD4
|
glyoxalase domain containing 4 |
chr19_-_55919087 | 34.03 |
ENST00000587845.1
ENST00000589978.1 ENST00000264552.9 |
UBE2S
|
ubiquitin-conjugating enzyme E2S |
chr6_-_32812420 | 33.82 |
ENST00000374881.2
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8 |
chr2_-_62115725 | 33.47 |
ENST00000538252.1
ENST00000544079.1 ENST00000394440.3 |
CCT4
|
chaperonin containing TCP1, subunit 4 (delta) |
chr2_-_62115659 | 31.97 |
ENST00000544185.1
|
CCT4
|
chaperonin containing TCP1, subunit 4 (delta) |
chr3_-_10028366 | 31.80 |
ENST00000429759.1
|
EMC3
|
ER membrane protein complex subunit 3 |
chr7_-_25164969 | 31.77 |
ENST00000305786.2
|
CYCS
|
cytochrome c, somatic |
chr6_-_53213780 | 31.05 |
ENST00000304434.6
ENST00000370918.4 |
ELOVL5
|
ELOVL fatty acid elongase 5 |
chr18_+_57567180 | 30.39 |
ENST00000316660.6
ENST00000269518.9 |
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1 |
chr19_+_36036477 | 30.30 |
ENST00000222284.5
ENST00000392204.2 |
TMEM147
|
transmembrane protein 147 |
chr6_+_47445467 | 29.53 |
ENST00000359314.5
|
CD2AP
|
CD2-associated protein |
chr1_-_115124257 | 28.97 |
ENST00000369541.3
|
BCAS2
|
breast carcinoma amplified sequence 2 |
chr19_-_40336969 | 28.93 |
ENST00000599134.1
ENST00000597634.1 ENST00000598417.1 ENST00000601274.1 ENST00000594309.1 ENST00000221801.3 |
FBL
|
fibrillarin |
chr14_+_105219437 | 28.77 |
ENST00000329967.6
ENST00000347067.5 ENST00000553810.1 |
SIVA1
|
SIVA1, apoptosis-inducing factor |
chr19_+_36036583 | 28.47 |
ENST00000392205.1
|
TMEM147
|
transmembrane protein 147 |
chr14_-_55369525 | 28.44 |
ENST00000543643.2
ENST00000536224.2 ENST00000395514.1 ENST00000491895.2 |
GCH1
|
GTP cyclohydrolase 1 |
chr4_+_113558612 | 28.36 |
ENST00000505034.1
ENST00000324052.6 |
LARP7
|
La ribonucleoprotein domain family, member 7 |
chr5_+_32531893 | 28.13 |
ENST00000512913.1
|
SUB1
|
SUB1 homolog (S. cerevisiae) |
chr22_-_36924944 | 27.97 |
ENST00000405442.1
ENST00000402116.1 |
EIF3D
|
eukaryotic translation initiation factor 3, subunit D |
chr5_-_133304473 | 27.83 |
ENST00000231512.3
|
C5orf15
|
chromosome 5 open reading frame 15 |
chr19_-_47616992 | 27.63 |
ENST00000253048.5
|
ZC3H4
|
zinc finger CCCH-type containing 4 |
chr4_-_122744998 | 27.57 |
ENST00000274026.5
|
CCNA2
|
cyclin A2 |
chr3_-_156877997 | 27.19 |
ENST00000295926.3
|
CCNL1
|
cyclin L1 |
chr16_+_30087288 | 27.12 |
ENST00000279387.7
ENST00000562664.1 ENST00000562222.1 |
PPP4C
|
protein phosphatase 4, catalytic subunit |
chr19_+_24009879 | 26.29 |
ENST00000354585.4
|
RPSAP58
|
ribosomal protein SA pseudogene 58 |
chr1_-_229644034 | 26.15 |
ENST00000366678.3
ENST00000261396.3 ENST00000537506.1 |
NUP133
|
nucleoporin 133kDa |
chr16_+_31044413 | 25.96 |
ENST00000394998.1
|
STX4
|
syntaxin 4 |
chr2_+_113403434 | 25.96 |
ENST00000272542.3
|
SLC20A1
|
solute carrier family 20 (phosphate transporter), member 1 |
chr9_+_70856899 | 25.85 |
ENST00000377342.5
ENST00000478048.1 |
CBWD3
|
COBW domain containing 3 |
chr7_+_56019486 | 25.60 |
ENST00000446692.1
ENST00000285298.4 ENST00000443449.1 |
GBAS
MRPS17
|
glioblastoma amplified sequence mitochondrial ribosomal protein S17 |
chr11_-_6633799 | 25.47 |
ENST00000299424.4
|
TAF10
|
TAF10 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 30kDa |
chr17_-_47785504 | 25.40 |
ENST00000514907.1
ENST00000503334.1 ENST00000508520.1 |
SLC35B1
|
solute carrier family 35, member B1 |
chr9_-_179018 | 25.28 |
ENST00000431099.2
ENST00000382447.4 ENST00000382389.1 ENST00000377447.3 ENST00000314367.10 ENST00000356521.4 ENST00000382393.1 ENST00000377400.4 |
CBWD1
|
COBW domain containing 1 |
chr9_-_69262509 | 25.14 |
ENST00000377449.1
ENST00000382399.4 ENST00000377439.1 ENST00000377441.1 ENST00000377457.5 |
CBWD6
|
COBW domain containing 6 |
chr5_+_44809027 | 25.09 |
ENST00000507110.1
|
MRPS30
|
mitochondrial ribosomal protein S30 |
chr12_-_112856623 | 24.85 |
ENST00000551291.2
|
RPL6
|
ribosomal protein L6 |
chr8_+_98788003 | 24.29 |
ENST00000521545.2
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta |
chr7_-_86849883 | 23.97 |
ENST00000433078.1
|
TMEM243
|
transmembrane protein 243, mitochondrial |
chr8_-_117778494 | 23.94 |
ENST00000276682.4
|
EIF3H
|
eukaryotic translation initiation factor 3, subunit H |
chr14_+_102276209 | 23.85 |
ENST00000445439.3
ENST00000334743.5 ENST00000557095.1 |
PPP2R5C
|
protein phosphatase 2, regulatory subunit B', gamma |
chr7_+_107531580 | 23.77 |
ENST00000537148.1
ENST00000440410.1 ENST00000437604.2 |
DLD
|
dihydrolipoamide dehydrogenase |
chr12_+_69979446 | 23.46 |
ENST00000543146.2
|
CCT2
|
chaperonin containing TCP1, subunit 2 (beta) |
chr14_+_93651358 | 23.34 |
ENST00000415050.2
|
TMEM251
|
transmembrane protein 251 |
chr15_+_66797627 | 23.25 |
ENST00000565627.1
ENST00000564179.1 |
ZWILCH
|
zwilch kinetochore protein |
chr12_+_69979210 | 23.22 |
ENST00000544368.2
|
CCT2
|
chaperonin containing TCP1, subunit 2 (beta) |
chr2_-_240964716 | 23.17 |
ENST00000404554.1
ENST00000407129.3 ENST00000307300.4 ENST00000443626.1 ENST00000252711.2 |
NDUFA10
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa |
chr17_+_56769924 | 23.15 |
ENST00000461271.1
ENST00000583539.1 ENST00000337432.4 ENST00000421782.2 |
RAD51C
|
RAD51 paralog C |
chr1_-_19536744 | 22.97 |
ENST00000375267.2
ENST00000375217.2 ENST00000375226.2 ENST00000375254.3 |
UBR4
|
ubiquitin protein ligase E3 component n-recognin 4 |
chr17_-_80231300 | 22.88 |
ENST00000398519.5
ENST00000580446.1 |
CSNK1D
|
casein kinase 1, delta |
chr12_+_51632638 | 22.85 |
ENST00000549732.2
|
DAZAP2
|
DAZ associated protein 2 |
chr19_+_1065922 | 22.74 |
ENST00000539243.2
|
HMHA1
|
histocompatibility (minor) HA-1 |
chr6_+_32812568 | 22.72 |
ENST00000414474.1
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9 |
chr2_+_114195268 | 22.69 |
ENST00000259199.4
ENST00000416503.2 ENST00000433343.2 |
CBWD2
|
COBW domain containing 2 |
chr15_+_66797455 | 22.62 |
ENST00000446801.2
|
ZWILCH
|
zwilch kinetochore protein |
chr8_+_26149007 | 22.57 |
ENST00000380737.3
ENST00000524169.1 |
PPP2R2A
|
protein phosphatase 2, regulatory subunit B, alpha |
chr11_-_3818932 | 22.14 |
ENST00000324932.7
ENST00000359171.4 |
NUP98
|
nucleoporin 98kDa |
chr12_+_72148614 | 22.12 |
ENST00000261263.3
|
RAB21
|
RAB21, member RAS oncogene family |
chr7_-_26240357 | 21.92 |
ENST00000354667.4
ENST00000356674.7 |
HNRNPA2B1
|
heterogeneous nuclear ribonucleoprotein A2/B1 |
chr11_-_3818688 | 21.86 |
ENST00000355260.3
ENST00000397004.4 ENST00000397007.4 ENST00000532475.1 |
NUP98
|
nucleoporin 98kDa |
chr12_+_69979113 | 21.78 |
ENST00000299300.6
|
CCT2
|
chaperonin containing TCP1, subunit 2 (beta) |
chr7_+_127228399 | 21.76 |
ENST00000000233.5
ENST00000415666.1 |
ARF5
|
ADP-ribosylation factor 5 |
chr15_-_66790146 | 21.63 |
ENST00000316634.5
|
SNAPC5
|
small nuclear RNA activating complex, polypeptide 5, 19kDa |
chr5_+_133707252 | 21.54 |
ENST00000506787.1
ENST00000507277.1 |
UBE2B
|
ubiquitin-conjugating enzyme E2B |
chr10_-_97416400 | 21.47 |
ENST00000371224.2
ENST00000371221.3 |
ALDH18A1
|
aldehyde dehydrogenase 18 family, member A1 |
chr14_+_50359773 | 21.37 |
ENST00000298316.5
|
ARF6
|
ADP-ribosylation factor 6 |
chr1_-_110950564 | 21.19 |
ENST00000256644.4
|
LAMTOR5
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5 |
chr15_+_52311398 | 20.84 |
ENST00000261845.5
|
MAPK6
|
mitogen-activated protein kinase 6 |
chr3_+_140660743 | 20.81 |
ENST00000453248.2
|
SLC25A36
|
solute carrier family 25 (pyrimidine nucleotide carrier ), member 36 |
chr11_+_18416103 | 20.63 |
ENST00000543445.1
ENST00000430553.2 ENST00000396222.2 ENST00000535451.1 |
LDHA
|
lactate dehydrogenase A |
chr11_+_4116054 | 20.62 |
ENST00000423050.2
|
RRM1
|
ribonucleotide reductase M1 |
chr8_+_42196000 | 20.58 |
ENST00000518925.1
ENST00000538005.1 |
POLB
|
polymerase (DNA directed), beta |
chr4_-_104119528 | 20.53 |
ENST00000380026.3
ENST00000503705.1 ENST00000265148.3 |
CENPE
|
centromere protein E, 312kDa |
chr1_-_32110467 | 20.44 |
ENST00000440872.2
ENST00000373703.4 |
PEF1
|
penta-EF-hand domain containing 1 |
chr7_-_23571586 | 20.41 |
ENST00000538367.1
ENST00000392502.4 ENST00000297071.4 |
TRA2A
|
transformer 2 alpha homolog (Drosophila) |
chrX_-_47518498 | 20.38 |
ENST00000335890.2
|
UXT
|
ubiquitously-expressed, prefoldin-like chaperone |
chr9_+_70856397 | 20.37 |
ENST00000360171.6
|
CBWD3
|
COBW domain containing 3 |
chr8_+_42195972 | 20.26 |
ENST00000532157.1
ENST00000265421.4 ENST00000520008.1 |
POLB
|
polymerase (DNA directed), beta |
chr16_-_81040719 | 20.13 |
ENST00000219400.3
|
CMC2
|
C-x(9)-C motif containing 2 |
chr6_-_31774714 | 20.11 |
ENST00000375661.5
|
LSM2
|
LSM2 homolog, U6 small nuclear RNA associated (S. cerevisiae) |
chr2_-_68290106 | 20.11 |
ENST00000407324.1
ENST00000355848.3 ENST00000409302.1 ENST00000410067.3 |
C1D
|
C1D nuclear receptor corepressor |
chr1_-_53704157 | 20.09 |
ENST00000371466.4
ENST00000371470.3 |
MAGOH
|
mago-nashi homolog, proliferation-associated (Drosophila) |
chr3_-_49066811 | 20.04 |
ENST00000442157.1
ENST00000326739.4 |
IMPDH2
|
IMP (inosine 5'-monophosphate) dehydrogenase 2 |
chr14_+_93651296 | 20.04 |
ENST00000283534.4
ENST00000557574.1 |
TMEM251
RP11-371E8.4
|
transmembrane protein 251 Uncharacterized protein |
chr14_-_50053081 | 19.90 |
ENST00000396020.3
ENST00000245458.6 |
RPS29
|
ribosomal protein S29 |
chr17_+_7476136 | 19.82 |
ENST00000582169.1
ENST00000578754.1 ENST00000578495.1 ENST00000293831.8 ENST00000380512.5 ENST00000585024.1 ENST00000583802.1 ENST00000577269.1 ENST00000584784.1 ENST00000582746.1 |
EIF4A1
|
eukaryotic translation initiation factor 4A1 |
chr8_-_103876383 | 19.74 |
ENST00000347770.4
|
AZIN1
|
antizyme inhibitor 1 |
chr4_-_76598544 | 19.65 |
ENST00000515457.1
ENST00000357854.3 |
G3BP2
|
GTPase activating protein (SH3 domain) binding protein 2 |
chr1_+_52082751 | 19.64 |
ENST00000447887.1
ENST00000435686.2 ENST00000428468.1 ENST00000453295.1 |
OSBPL9
|
oxysterol binding protein-like 9 |
chr11_+_4116005 | 19.64 |
ENST00000300738.5
|
RRM1
|
ribonucleotide reductase M1 |
chr22_-_36925186 | 19.61 |
ENST00000541106.1
ENST00000455547.1 ENST00000432675.1 |
EIF3D
|
eukaryotic translation initiation factor 3, subunit D |
chr3_-_49142178 | 19.60 |
ENST00000452739.1
ENST00000414533.1 ENST00000417025.1 |
QARS
|
glutaminyl-tRNA synthetase |
chr17_+_7155556 | 19.60 |
ENST00000570500.1
ENST00000574993.1 ENST00000396628.2 ENST00000573657.1 |
ELP5
|
elongator acetyltransferase complex subunit 5 |
chr19_+_50180409 | 19.59 |
ENST00000391851.4
|
PRMT1
|
protein arginine methyltransferase 1 |
chr20_-_48729670 | 19.55 |
ENST00000371657.5
|
UBE2V1
|
ubiquitin-conjugating enzyme E2 variant 1 |
chr19_-_59066327 | 19.55 |
ENST00000596708.1
ENST00000601220.1 ENST00000597848.1 |
CHMP2A
|
charged multivesicular body protein 2A |
chr14_+_55518349 | 19.52 |
ENST00000395468.4
|
MAPK1IP1L
|
mitogen-activated protein kinase 1 interacting protein 1-like |
chr19_-_8070474 | 19.47 |
ENST00000407627.2
ENST00000593807.1 |
ELAVL1
|
ELAV like RNA binding protein 1 |
chr11_+_118230287 | 19.14 |
ENST00000252108.3
ENST00000431736.2 |
UBE4A
|
ubiquitination factor E4A |
chr5_-_133561752 | 19.13 |
ENST00000519718.1
ENST00000481195.1 |
CTD-2410N18.5
PPP2CA
|
S-phase kinase-associated protein 1 protein phosphatase 2, catalytic subunit, alpha isozyme |
chr6_-_43027105 | 19.10 |
ENST00000230413.5
ENST00000487429.1 ENST00000489623.1 ENST00000468957.1 |
MRPL2
|
mitochondrial ribosomal protein L2 |
chr7_+_116660246 | 19.03 |
ENST00000434836.1
ENST00000393443.1 ENST00000465133.1 ENST00000477742.1 ENST00000393447.4 ENST00000393444.3 |
ST7
|
suppression of tumorigenicity 7 |
chr5_-_10761206 | 18.95 |
ENST00000432074.2
ENST00000230895.6 |
DAP
|
death-associated protein |
chr12_-_102455846 | 18.95 |
ENST00000545679.1
|
CCDC53
|
coiled-coil domain containing 53 |
chr8_+_126442563 | 18.75 |
ENST00000311922.3
|
TRIB1
|
tribbles pseudokinase 1 |
chr17_+_15902694 | 18.48 |
ENST00000261647.5
ENST00000486880.2 |
TTC19
|
tetratricopeptide repeat domain 19 |
chr11_-_64546202 | 18.44 |
ENST00000377390.3
ENST00000227503.9 ENST00000377394.3 ENST00000422298.2 ENST00000334944.5 |
SF1
|
splicing factor 1 |
chr12_-_14956396 | 18.31 |
ENST00000535328.1
ENST00000261167.2 |
WBP11
|
WW domain binding protein 11 |
chr12_+_56521840 | 18.26 |
ENST00000394048.5
|
ESYT1
|
extended synaptotagmin-like protein 1 |
chr17_-_8113542 | 18.24 |
ENST00000578549.1
ENST00000535053.1 ENST00000582368.1 |
AURKB
|
aurora kinase B |
chr12_+_98987369 | 18.20 |
ENST00000401722.3
ENST00000188376.5 ENST00000228318.3 ENST00000551917.1 ENST00000548046.1 ENST00000552981.1 ENST00000551265.1 ENST00000550695.1 ENST00000547534.1 ENST00000549338.1 ENST00000548847.1 |
SLC25A3
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3 |
chr8_-_101964231 | 18.18 |
ENST00000521309.1
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta |
chr7_+_120591170 | 18.11 |
ENST00000431467.1
|
ING3
|
inhibitor of growth family, member 3 |
chr9_-_70490107 | 18.10 |
ENST00000377395.4
ENST00000429800.2 ENST00000430059.2 ENST00000377384.1 ENST00000382405.3 |
CBWD5
|
COBW domain containing 5 |
chr5_+_5422778 | 18.08 |
ENST00000296564.7
|
KIAA0947
|
KIAA0947 |
chr7_-_137686791 | 17.99 |
ENST00000452463.1
ENST00000330387.6 ENST00000456390.1 |
CREB3L2
|
cAMP responsive element binding protein 3-like 2 |
chr17_-_47785265 | 17.91 |
ENST00000511763.1
ENST00000515850.1 ENST00000415270.2 ENST00000240333.6 |
SLC35B1
|
solute carrier family 35, member B1 |
chrX_-_47518527 | 17.81 |
ENST00000333119.3
|
UXT
|
ubiquitously-expressed, prefoldin-like chaperone |
chr14_+_60715928 | 17.74 |
ENST00000395076.4
|
PPM1A
|
protein phosphatase, Mg2+/Mn2+ dependent, 1A |
chr12_-_102455902 | 17.68 |
ENST00000240079.6
|
CCDC53
|
coiled-coil domain containing 53 |
chr11_+_18416133 | 17.65 |
ENST00000227157.4
ENST00000478970.2 ENST00000495052.1 |
LDHA
|
lactate dehydrogenase A |
chr1_-_159894319 | 17.65 |
ENST00000320307.4
|
TAGLN2
|
transgelin 2 |
chr1_+_45205478 | 17.53 |
ENST00000452259.1
ENST00000372224.4 |
KIF2C
|
kinesin family member 2C |
chr21_-_40720995 | 17.38 |
ENST00000380749.5
|
HMGN1
|
high mobility group nucleosome binding domain 1 |
chr7_+_26240776 | 17.28 |
ENST00000337620.4
|
CBX3
|
chromobox homolog 3 |
chr17_+_685513 | 17.18 |
ENST00000304478.4
|
RNMTL1
|
RNA methyltransferase like 1 |
chr10_+_35484793 | 17.04 |
ENST00000488741.1
ENST00000474931.1 ENST00000468236.1 ENST00000344351.5 ENST00000490511.1 |
CREM
|
cAMP responsive element modulator |
chr20_-_48732472 | 17.03 |
ENST00000340309.3
ENST00000415862.2 ENST00000371677.3 ENST00000420027.2 |
UBE2V1
|
ubiquitin-conjugating enzyme E2 variant 1 |
chr6_+_64281906 | 16.96 |
ENST00000370651.3
|
PTP4A1
|
protein tyrosine phosphatase type IVA, member 1 |
chr8_+_125486939 | 16.93 |
ENST00000303545.3
|
RNF139
|
ring finger protein 139 |
chr19_-_59066452 | 16.88 |
ENST00000312547.2
|
CHMP2A
|
charged multivesicular body protein 2A |
chr9_-_111696224 | 16.82 |
ENST00000537196.1
|
IKBKAP
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein |
chr17_-_77813186 | 16.68 |
ENST00000448310.1
ENST00000269397.4 |
CBX4
|
chromobox homolog 4 |
chr2_+_187350883 | 16.67 |
ENST00000337859.6
|
ZC3H15
|
zinc finger CCCH-type containing 15 |
chrX_+_77359671 | 16.52 |
ENST00000373316.4
|
PGK1
|
phosphoglycerate kinase 1 |
chr19_+_16186903 | 16.47 |
ENST00000588507.1
|
TPM4
|
tropomyosin 4 |
chr1_+_45205498 | 16.37 |
ENST00000372218.4
|
KIF2C
|
kinesin family member 2C |
chr19_-_39881777 | 16.37 |
ENST00000595564.1
ENST00000221265.3 |
PAF1
|
Paf1, RNA polymerase II associated factor, homolog (S. cerevisiae) |
chr14_+_74353508 | 16.33 |
ENST00000324593.6
ENST00000557495.1 ENST00000556659.1 ENST00000557363.1 |
ZNF410
|
zinc finger protein 410 |
chrX_+_77359726 | 16.24 |
ENST00000442431.1
|
PGK1
|
phosphoglycerate kinase 1 |
chr17_-_61850894 | 16.03 |
ENST00000403162.3
ENST00000582252.1 ENST00000225726.5 |
CCDC47
|
coiled-coil domain containing 47 |
chr8_-_117768023 | 15.93 |
ENST00000518949.1
ENST00000522453.1 ENST00000521861.1 ENST00000518995.1 |
EIF3H
|
eukaryotic translation initiation factor 3, subunit H |
chr19_-_9546227 | 15.93 |
ENST00000361451.2
ENST00000361151.1 |
ZNF266
|
zinc finger protein 266 |
chr11_+_65337901 | 15.91 |
ENST00000309328.3
ENST00000531405.1 ENST00000527920.1 ENST00000526877.1 ENST00000533115.1 ENST00000526433.1 |
SSSCA1
|
Sjogren syndrome/scleroderma autoantigen 1 |
chr19_-_18392422 | 15.91 |
ENST00000252818.3
|
JUND
|
jun D proto-oncogene |
chr12_-_82752565 | 15.76 |
ENST00000256151.7
|
CCDC59
|
coiled-coil domain containing 59 |
chr17_-_47841485 | 15.69 |
ENST00000506156.1
ENST00000240364.2 |
FAM117A
|
family with sequence similarity 117, member A |
chr1_-_70671216 | 15.66 |
ENST00000370952.3
|
LRRC40
|
leucine rich repeat containing 40 |
chr1_+_228327943 | 15.57 |
ENST00000366726.1
ENST00000312726.4 ENST00000366728.2 ENST00000453943.1 ENST00000366723.1 ENST00000366722.1 ENST00000435153.1 ENST00000366721.1 |
GUK1
|
guanylate kinase 1 |
chr7_+_120590803 | 15.47 |
ENST00000315870.5
ENST00000339121.5 ENST00000445699.1 |
ING3
|
inhibitor of growth family, member 3 |
chr12_+_51632600 | 15.47 |
ENST00000549555.1
ENST00000439799.2 ENST00000425012.2 |
DAZAP2
|
DAZ associated protein 2 |
chr3_+_180630444 | 15.47 |
ENST00000491062.1
ENST00000468861.1 ENST00000445140.2 ENST00000484958.1 |
FXR1
|
fragile X mental retardation, autosomal homolog 1 |
chr2_+_118572226 | 15.30 |
ENST00000263239.2
|
DDX18
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 18 |
chr10_+_13203543 | 15.29 |
ENST00000378714.3
ENST00000479669.1 ENST00000484800.2 |
MCM10
|
minichromosome maintenance complex component 10 |
chr19_-_14530143 | 15.21 |
ENST00000242776.4
|
DDX39A
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A |
chrX_+_153672468 | 15.19 |
ENST00000393600.3
|
FAM50A
|
family with sequence similarity 50, member A |
chr8_-_101964265 | 15.19 |
ENST00000395958.2
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta |
chr16_+_3068393 | 15.12 |
ENST00000573001.1
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A |
chr5_+_162887556 | 15.12 |
ENST00000393915.4
ENST00000432118.2 ENST00000358715.3 |
HMMR
|
hyaluronan-mediated motility receptor (RHAMM) |
chr8_+_23386557 | 15.10 |
ENST00000523930.1
|
SLC25A37
|
solute carrier family 25 (mitochondrial iron transporter), member 37 |
chr4_-_54930790 | 14.92 |
ENST00000263921.3
|
CHIC2
|
cysteine-rich hydrophobic domain 2 |
chr22_+_24236191 | 14.87 |
ENST00000215754.7
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
chr14_+_74353574 | 14.85 |
ENST00000442160.3
ENST00000555044.1 |
ZNF410
|
zinc finger protein 410 |
chr12_+_69633372 | 14.83 |
ENST00000456847.3
ENST00000266679.8 |
CPSF6
|
cleavage and polyadenylation specific factor 6, 68kDa |
chr18_+_20513278 | 14.60 |
ENST00000327155.5
|
RBBP8
|
retinoblastoma binding protein 8 |
chr17_+_33914460 | 14.57 |
ENST00000537622.2
|
AP2B1
|
adaptor-related protein complex 2, beta 1 subunit |
chr12_+_51632508 | 14.52 |
ENST00000449723.3
|
DAZAP2
|
DAZ associated protein 2 |
chr12_+_54378923 | 14.46 |
ENST00000303460.4
|
HOXC10
|
homeobox C10 |
chr1_+_228327923 | 14.46 |
ENST00000391865.3
|
GUK1
|
guanylate kinase 1 |
chr22_+_39898325 | 14.42 |
ENST00000325301.2
ENST00000404569.1 |
MIEF1
|
mitochondrial elongation factor 1 |
chr17_+_7155819 | 14.39 |
ENST00000570322.1
ENST00000576496.1 ENST00000574841.2 |
ELP5
|
elongator acetyltransferase complex subunit 5 |
chr4_-_84205905 | 14.30 |
ENST00000311461.7
ENST00000311469.4 ENST00000439031.2 |
COQ2
|
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase |
chr3_+_180630090 | 14.30 |
ENST00000357559.4
ENST00000305586.7 |
FXR1
|
fragile X mental retardation, autosomal homolog 1 |
chr17_+_33914276 | 14.19 |
ENST00000592545.1
ENST00000538556.1 ENST00000312678.8 ENST00000589344.1 |
AP2B1
|
adaptor-related protein complex 2, beta 1 subunit |
chr1_-_110950255 | 14.16 |
ENST00000483260.1
ENST00000474861.2 ENST00000602318.1 |
LAMTOR5
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5 |
chr12_+_75874460 | 14.16 |
ENST00000266659.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr12_+_113344755 | 14.06 |
ENST00000550883.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr20_-_48729696 | 14.04 |
ENST00000371674.3
|
UBE2V1
|
ubiquitin-conjugating enzyme E2 variant 1 |
chr1_+_95616933 | 14.04 |
ENST00000604203.1
|
RP11-57H12.6
|
TMEM56-RWDD3 readthrough |
chr16_-_3767506 | 14.01 |
ENST00000538171.1
|
TRAP1
|
TNF receptor-associated protein 1 |
chr19_+_49375649 | 13.98 |
ENST00000200453.5
|
PPP1R15A
|
protein phosphatase 1, regulatory subunit 15A |
chr7_-_45151272 | 13.93 |
ENST00000461363.1
ENST00000495078.1 ENST00000494076.1 ENST00000478532.1 ENST00000258770.3 ENST00000361278.3 |
TBRG4
|
transforming growth factor beta regulator 4 |
chr7_+_23221613 | 13.89 |
ENST00000410002.3
ENST00000413919.1 |
NUPL2
|
nucleoporin like 2 |
chr1_+_39456895 | 13.80 |
ENST00000432648.3
ENST00000446189.2 ENST00000372984.4 |
AKIRIN1
|
akirin 1 |
chr16_+_81040794 | 13.78 |
ENST00000439957.3
ENST00000393335.3 ENST00000428963.2 ENST00000564669.1 |
CENPN
|
centromere protein N |
chr21_-_44846999 | 13.63 |
ENST00000270162.6
|
SIK1
|
salt-inducible kinase 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
22.8 | 68.5 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
16.1 | 48.2 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
15.9 | 47.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
14.4 | 43.3 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
14.3 | 43.0 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
13.6 | 40.8 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
12.9 | 38.7 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
12.1 | 36.4 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
12.0 | 12.0 | GO:0043103 | hypoxanthine salvage(GO:0043103) |
11.6 | 69.7 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
11.3 | 34.0 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
10.6 | 31.7 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
10.0 | 30.0 | GO:0009183 | purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
9.9 | 29.7 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
9.8 | 29.5 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
9.6 | 38.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
9.5 | 28.5 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
9.3 | 65.4 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
9.0 | 27.1 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
9.0 | 26.9 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
8.9 | 26.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
8.8 | 44.0 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
8.3 | 58.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
7.9 | 7.9 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
7.8 | 23.5 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
7.2 | 28.9 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
7.1 | 28.4 | GO:0046833 | snRNA export from nucleus(GO:0006408) positive regulation of RNA export from nucleus(GO:0046833) |
6.9 | 27.6 | GO:0071373 | cellular response to luteinizing hormone stimulus(GO:0071373) |
6.6 | 26.5 | GO:0009386 | translational attenuation(GO:0009386) |
6.5 | 26.1 | GO:0051664 | nuclear pore distribution(GO:0031081) nuclear pore localization(GO:0051664) |
6.5 | 6.5 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
6.5 | 19.5 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
6.4 | 25.5 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
6.2 | 18.7 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
6.0 | 18.1 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
5.7 | 28.4 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
5.4 | 16.1 | GO:0070510 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
5.2 | 31.5 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
5.2 | 41.7 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
5.2 | 20.7 | GO:0009106 | lipoate metabolic process(GO:0009106) |
5.0 | 14.9 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
4.9 | 19.8 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
4.9 | 19.7 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
4.8 | 14.5 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
4.8 | 29.0 | GO:0006561 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
4.7 | 14.2 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
4.7 | 14.0 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
4.6 | 22.8 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
4.6 | 72.8 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
4.5 | 13.5 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
4.5 | 17.9 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
4.4 | 21.9 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
4.1 | 28.9 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
4.1 | 28.5 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
3.9 | 55.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
3.8 | 11.5 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) regulation of genetic imprinting(GO:2000653) |
3.8 | 7.7 | GO:0002188 | translation reinitiation(GO:0002188) |
3.7 | 18.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
3.6 | 10.8 | GO:0000967 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
3.6 | 21.6 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
3.4 | 20.6 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
3.4 | 6.8 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
3.4 | 23.6 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
3.3 | 20.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
3.3 | 13.2 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
3.3 | 23.0 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
3.1 | 40.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
3.1 | 37.5 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
3.1 | 21.5 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
3.1 | 30.7 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
3.0 | 27.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
3.0 | 8.9 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
2.9 | 26.5 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
2.9 | 17.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
2.9 | 8.6 | GO:0097212 | cleavage furrow ingression(GO:0036090) lysosomal membrane organization(GO:0097212) regulation of late endosome to lysosome transport(GO:1902822) |
2.8 | 16.9 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
2.8 | 16.9 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
2.8 | 8.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
2.8 | 5.6 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
2.7 | 27.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
2.7 | 27.2 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
2.7 | 8.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
2.7 | 13.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
2.7 | 26.7 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
2.7 | 47.7 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
2.7 | 8.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
2.6 | 15.7 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) histone H3-T11 phosphorylation(GO:0035407) |
2.6 | 10.5 | GO:1903660 | negative regulation of complement-dependent cytotoxicity(GO:1903660) |
2.6 | 34.0 | GO:0006089 | lactate metabolic process(GO:0006089) |
2.5 | 5.1 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
2.4 | 12.1 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
2.4 | 40.3 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
2.4 | 7.1 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
2.4 | 21.2 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
2.3 | 18.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
2.3 | 7.0 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
2.3 | 9.2 | GO:1902544 | oxidative DNA demethylation(GO:0035511) regulation of DNA N-glycosylase activity(GO:1902544) |
2.3 | 2.3 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
2.3 | 6.8 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
2.3 | 33.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
2.2 | 33.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
2.2 | 8.9 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
2.2 | 22.1 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
2.2 | 4.4 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
2.2 | 8.7 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
2.2 | 19.5 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
2.1 | 8.6 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
2.1 | 2.1 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
2.1 | 6.4 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
2.1 | 8.5 | GO:0043335 | protein unfolding(GO:0043335) |
2.1 | 4.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
2.1 | 16.9 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
2.1 | 12.6 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
2.1 | 8.4 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
2.0 | 36.9 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
2.0 | 32.8 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
2.0 | 32.5 | GO:0045116 | protein neddylation(GO:0045116) |
2.0 | 16.2 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
2.0 | 20.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
2.0 | 5.9 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
1.9 | 9.7 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
1.9 | 1.9 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
1.9 | 7.7 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
1.9 | 25.0 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
1.9 | 9.6 | GO:0019348 | dolichol metabolic process(GO:0019348) |
1.9 | 28.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
1.9 | 41.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
1.8 | 14.5 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
1.8 | 19.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
1.8 | 10.6 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
1.8 | 5.3 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
1.8 | 8.8 | GO:0048539 | bone marrow development(GO:0048539) |
1.7 | 12.2 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
1.7 | 5.2 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
1.7 | 84.0 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
1.7 | 12.0 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
1.7 | 13.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.7 | 6.7 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
1.7 | 11.7 | GO:0032202 | telomere assembly(GO:0032202) |
1.7 | 6.6 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
1.7 | 29.8 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
1.6 | 8.2 | GO:0060356 | leucine import(GO:0060356) |
1.6 | 9.9 | GO:0051025 | negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
1.6 | 27.8 | GO:0006265 | DNA topological change(GO:0006265) |
1.6 | 9.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
1.6 | 12.9 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
1.6 | 8.0 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.6 | 11.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
1.6 | 6.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
1.6 | 14.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
1.6 | 1.6 | GO:1903973 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
1.6 | 4.7 | GO:0031938 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) regulation of chromatin silencing at telomere(GO:0031938) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
1.6 | 12.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
1.5 | 10.7 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
1.5 | 9.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.5 | 6.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
1.5 | 9.1 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
1.5 | 4.5 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
1.5 | 4.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
1.5 | 5.9 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
1.5 | 28.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
1.5 | 61.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
1.4 | 7.2 | GO:0080009 | mRNA methylation(GO:0080009) |
1.4 | 2.9 | GO:0010628 | positive regulation of gene expression(GO:0010628) |
1.4 | 5.7 | GO:0090135 | actin filament branching(GO:0090135) |
1.4 | 7.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
1.4 | 27.0 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
1.4 | 7.0 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
1.4 | 2.8 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
1.3 | 9.4 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
1.3 | 1.3 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
1.3 | 21.4 | GO:0036010 | protein localization to endosome(GO:0036010) |
1.3 | 5.3 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
1.3 | 4.0 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
1.3 | 7.9 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
1.3 | 10.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.3 | 4.0 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
1.3 | 7.9 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
1.3 | 11.7 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
1.3 | 5.2 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
1.3 | 37.6 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
1.3 | 91.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) mitochondrial translational termination(GO:0070126) |
1.2 | 37.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
1.2 | 8.7 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
1.2 | 33.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
1.2 | 33.3 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
1.2 | 4.9 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
1.2 | 102.2 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
1.2 | 29.8 | GO:0031639 | plasminogen activation(GO:0031639) |
1.2 | 2.4 | GO:0006788 | heme oxidation(GO:0006788) |
1.2 | 7.1 | GO:0015853 | adenine transport(GO:0015853) |
1.2 | 7.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
1.2 | 4.7 | GO:0003164 | His-Purkinje system development(GO:0003164) |
1.2 | 4.7 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
1.2 | 8.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.2 | 11.6 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
1.2 | 1.2 | GO:0051604 | protein maturation(GO:0051604) |
1.1 | 4.6 | GO:0030242 | pexophagy(GO:0030242) |
1.1 | 6.8 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
1.1 | 26.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
1.1 | 9.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
1.1 | 3.4 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) negative regulation of gastrulation(GO:2000542) |
1.1 | 29.9 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
1.1 | 12.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
1.1 | 4.4 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.1 | 19.6 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
1.1 | 4.3 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
1.1 | 3.2 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.0 | 6.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
1.0 | 19.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
1.0 | 3.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
1.0 | 9.3 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
1.0 | 1.0 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
1.0 | 4.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.0 | 14.9 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
1.0 | 4.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.0 | 10.8 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
1.0 | 77.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.0 | 2.9 | GO:0060278 | negative regulation of B cell differentiation(GO:0045578) regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
1.0 | 1.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.0 | 15.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.9 | 35.9 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.9 | 1.9 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) positive regulation of catagen(GO:0051795) |
0.9 | 9.4 | GO:0010225 | response to UV-C(GO:0010225) |
0.9 | 8.3 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.9 | 5.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.9 | 3.6 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
0.9 | 8.2 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) positive regulation by host of viral genome replication(GO:0044829) |
0.9 | 2.7 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
0.9 | 6.3 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.9 | 3.6 | GO:0030307 | positive regulation of cell growth(GO:0030307) |
0.9 | 2.7 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.9 | 8.0 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.9 | 8.0 | GO:0032264 | IMP salvage(GO:0032264) |
0.9 | 6.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.9 | 9.5 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.9 | 9.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.8 | 28.0 | GO:0031648 | protein destabilization(GO:0031648) |
0.8 | 3.4 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.8 | 5.9 | GO:0000012 | single strand break repair(GO:0000012) |
0.8 | 7.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.8 | 13.8 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.8 | 52.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.8 | 25.6 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.8 | 1.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.8 | 16.6 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.8 | 4.7 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.8 | 17.9 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.8 | 4.6 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.8 | 8.4 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.8 | 7.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.8 | 20.4 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.7 | 3.0 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.7 | 20.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.7 | 29.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.7 | 9.5 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.7 | 10.2 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.7 | 5.8 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.7 | 2.9 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.7 | 2.9 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.7 | 3.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.7 | 4.3 | GO:0032496 | response to lipopolysaccharide(GO:0032496) |
0.7 | 15.7 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.7 | 6.4 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.7 | 7.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.7 | 1.4 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.7 | 1.4 | GO:0090298 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.7 | 3.5 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.7 | 4.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.7 | 0.7 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
0.7 | 70.7 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.7 | 7.4 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.7 | 3.3 | GO:0002027 | regulation of heart rate(GO:0002027) |
0.7 | 7.3 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.7 | 2.0 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
0.7 | 14.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.7 | 2.0 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.7 | 2.0 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.6 | 5.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.6 | 7.6 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.6 | 1.3 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.6 | 3.8 | GO:1904044 | response to aldosterone(GO:1904044) |
0.6 | 3.7 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.6 | 0.6 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.6 | 1.8 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.6 | 2.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.6 | 6.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.6 | 9.0 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.6 | 1.2 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.6 | 10.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.6 | 4.6 | GO:1904872 | RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) regulation of telomerase RNA localization to Cajal body(GO:1904872) |
0.6 | 3.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.5 | 6.6 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.5 | 14.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.5 | 7.6 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.5 | 3.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.5 | 27.6 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.5 | 2.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.5 | 4.8 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.5 | 1.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.5 | 5.8 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.5 | 2.1 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) |
0.5 | 3.2 | GO:1903543 | positive regulation of exosomal secretion(GO:1903543) |
0.5 | 5.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.5 | 19.7 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.5 | 3.6 | GO:0006116 | NADH oxidation(GO:0006116) |
0.5 | 6.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.5 | 29.6 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.5 | 3.6 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.5 | 2.0 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.5 | 24.9 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.5 | 2.5 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
0.5 | 1.5 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.5 | 50.8 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.5 | 6.4 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
0.5 | 4.4 | GO:0030099 | myeloid cell differentiation(GO:0030099) |
0.5 | 1.9 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.5 | 10.1 | GO:0044764 | multi-organism cellular process(GO:0044764) |
0.5 | 4.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.5 | 1.9 | GO:0030035 | microspike assembly(GO:0030035) |
0.5 | 12.9 | GO:0002076 | osteoblast development(GO:0002076) |
0.5 | 2.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.5 | 6.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.5 | 9.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.5 | 0.5 | GO:0002874 | chronic inflammatory response to antigenic stimulus(GO:0002439) regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.5 | 3.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.5 | 2.3 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) regulation of t-circle formation(GO:1904429) positive regulation of t-circle formation(GO:1904431) |
0.5 | 6.9 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.5 | 8.2 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.5 | 5.0 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.4 | 8.0 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.4 | 2.6 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.4 | 8.2 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.4 | 1.7 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.4 | 2.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.4 | 2.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.4 | 7.7 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.4 | 1.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.4 | 6.0 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
0.4 | 1.3 | GO:0042351 | GDP-L-fucose biosynthetic process(GO:0042350) 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.4 | 5.9 | GO:0051014 | actin filament severing(GO:0051014) |
0.4 | 81.7 | GO:0006413 | translational initiation(GO:0006413) |
0.4 | 3.4 | GO:0001878 | response to yeast(GO:0001878) |
0.4 | 6.6 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.4 | 3.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.4 | 1.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.4 | 3.6 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.4 | 10.8 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.4 | 3.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.4 | 76.4 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.4 | 14.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.4 | 1.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.4 | 94.0 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.4 | 1.1 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.4 | 4.2 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.4 | 1.9 | GO:0016045 | detection of bacterium(GO:0016045) |
0.4 | 8.0 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.4 | 3.3 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.4 | 37.2 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.3 | 1.0 | GO:0061743 | motor learning(GO:0061743) |
0.3 | 4.1 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.3 | 2.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.3 | 1.7 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.3 | 2.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.3 | 1.3 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.3 | 0.3 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.3 | 0.7 | GO:1904502 | lipophagy(GO:0061724) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.3 | 1.3 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 2.2 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.3 | 14.3 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.3 | 3.5 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.3 | 2.5 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.3 | 5.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.3 | 2.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.3 | 4.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.3 | 1.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.3 | 6.7 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.3 | 17.1 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.3 | 3.8 | GO:0019985 | translesion synthesis(GO:0019985) |
0.3 | 1.7 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.3 | 2.0 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.3 | 1.1 | GO:0048743 | regulation of skeletal muscle fiber development(GO:0048742) positive regulation of skeletal muscle fiber development(GO:0048743) |
0.3 | 6.5 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.3 | 1.7 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 0.8 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.3 | 6.6 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.3 | 0.8 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.3 | 12.5 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.3 | 1.6 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.3 | 5.1 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.3 | 16.9 | GO:0030148 | sphingolipid biosynthetic process(GO:0030148) |
0.3 | 3.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.3 | 6.2 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.3 | 0.8 | GO:0090656 | t-circle formation(GO:0090656) |
0.3 | 0.5 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
0.2 | 20.2 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.2 | 1.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 8.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 0.5 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.2 | 8.2 | GO:0002576 | platelet degranulation(GO:0002576) |
0.2 | 2.8 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 1.9 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 2.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.2 | 10.8 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.2 | 1.8 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 1.8 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
0.2 | 2.9 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
0.2 | 1.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 2.0 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.2 | 3.3 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 1.1 | GO:0051924 | regulation of calcium ion transport(GO:0051924) |
0.2 | 2.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 1.4 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.2 | 1.8 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.2 | 0.6 | GO:1903795 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) regulation of inorganic anion transmembrane transport(GO:1903795) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.2 | 10.7 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.2 | 0.8 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 1.5 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) negative regulation of dendritic spine maintenance(GO:1902951) |
0.2 | 0.9 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.2 | 1.7 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 7.2 | GO:0061621 | NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.2 | 1.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 1.3 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.2 | 9.4 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 1.0 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.2 | 0.9 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 4.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 | 0.5 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.2 | 1.0 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 3.5 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.2 | 6.8 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 2.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 2.7 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 2.6 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.6 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) primary lung bud formation(GO:0060431) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 1.2 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.1 | 0.7 | GO:2001214 | blood vessel endothelial cell differentiation(GO:0060837) arterial endothelial cell differentiation(GO:0060842) positive regulation of vasculogenesis(GO:2001214) |
0.1 | 2.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 4.0 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.1 | 0.8 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.9 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.1 | 1.5 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 10.4 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.1 | 7.8 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 3.7 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 3.4 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 2.2 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.6 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 1.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.9 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 1.0 | GO:0051781 | positive regulation of cell division(GO:0051781) |
0.1 | 2.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.3 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.1 | 10.3 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
0.1 | 0.5 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 3.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 3.7 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.4 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.1 | 9.6 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.1 | 1.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 2.4 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.1 | 2.8 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.1 | 1.3 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.3 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.1 | 0.4 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.1 | 1.5 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.8 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.8 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 2.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.7 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 1.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 1.5 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 3.8 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 0.1 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.1 | 1.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 2.0 | GO:0009083 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.3 | GO:0055093 | response to hyperoxia(GO:0055093) |
0.1 | 1.8 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.9 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.9 | GO:0030728 | ovulation(GO:0030728) |
0.1 | 0.3 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 1.0 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 1.0 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.6 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.8 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 1.0 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.0 | 0.4 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.7 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.0 | 1.8 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 1.7 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 0.1 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of luteinizing hormone secretion(GO:0033686) |
0.0 | 1.3 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.0 | 0.3 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.6 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.0 | 2.8 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.0 | 0.6 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.5 | GO:0001889 | liver development(GO:0001889) hepaticobiliary system development(GO:0061008) |
0.0 | 4.1 | GO:0019216 | regulation of lipid metabolic process(GO:0019216) |
0.0 | 0.2 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.2 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.0 | 0.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.2 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.0 | 0.6 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.0 | 0.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.5 | GO:0016925 | protein sumoylation(GO:0016925) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.3 | 61.3 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
12.0 | 47.9 | GO:0042025 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
11.4 | 45.7 | GO:1990423 | RZZ complex(GO:1990423) |
11.3 | 33.9 | GO:0097447 | dendritic tree(GO:0097447) |
10.8 | 32.3 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
10.1 | 131.0 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
10.1 | 40.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
9.7 | 87.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
9.6 | 28.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
9.0 | 27.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
8.7 | 69.6 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
7.7 | 30.9 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
7.7 | 46.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
7.1 | 28.4 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
7.1 | 35.4 | GO:0071986 | Ragulator complex(GO:0071986) |
6.9 | 20.7 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
6.6 | 59.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
6.6 | 19.7 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
5.5 | 98.7 | GO:0034709 | methylosome(GO:0034709) |
5.4 | 26.9 | GO:0033503 | HULC complex(GO:0033503) |
5.2 | 41.8 | GO:0000322 | storage vacuole(GO:0000322) |
5.0 | 15.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
5.0 | 59.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
4.7 | 18.8 | GO:0000799 | nuclear condensin complex(GO:0000799) |
4.6 | 13.7 | GO:1902636 | kinociliary basal body(GO:1902636) |
4.5 | 13.5 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
4.0 | 16.1 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
3.7 | 76.8 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
3.6 | 32.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
3.6 | 10.8 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
3.6 | 28.5 | GO:0070552 | BRISC complex(GO:0070552) |
3.5 | 13.9 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
3.4 | 27.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
3.4 | 16.9 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
3.4 | 10.1 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
3.1 | 63.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
3.1 | 12.5 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
3.0 | 15.0 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
2.8 | 96.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
2.8 | 25.5 | GO:0000125 | PCAF complex(GO:0000125) |
2.8 | 8.5 | GO:0001741 | XY body(GO:0001741) |
2.8 | 22.4 | GO:0042382 | paraspeckles(GO:0042382) |
2.8 | 35.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
2.7 | 19.1 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
2.7 | 8.2 | GO:0030689 | Noc complex(GO:0030689) |
2.6 | 7.7 | GO:0071159 | NF-kappaB complex(GO:0071159) |
2.5 | 48.0 | GO:0036020 | endolysosome membrane(GO:0036020) |
2.5 | 20.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
2.4 | 19.4 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
2.4 | 14.5 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
2.3 | 32.9 | GO:0090543 | Flemming body(GO:0090543) |
2.3 | 4.7 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
2.2 | 35.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
2.2 | 6.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
2.1 | 17.1 | GO:0035976 | AP1 complex(GO:0035976) |
2.1 | 10.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
2.0 | 20.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.9 | 11.7 | GO:0008537 | proteasome activator complex(GO:0008537) |
1.9 | 21.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.9 | 11.5 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
1.9 | 7.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
1.8 | 55.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
1.8 | 38.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
1.8 | 20.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
1.8 | 16.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.8 | 3.6 | GO:0030870 | Mre11 complex(GO:0030870) |
1.8 | 5.4 | GO:0031523 | Myb complex(GO:0031523) |
1.6 | 17.9 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
1.6 | 6.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.6 | 16.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
1.6 | 14.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
1.6 | 44.1 | GO:0031143 | pseudopodium(GO:0031143) |
1.6 | 9.4 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
1.5 | 5.8 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
1.4 | 78.0 | GO:0005876 | spindle microtubule(GO:0005876) |
1.4 | 17.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
1.4 | 7.1 | GO:0071817 | MMXD complex(GO:0071817) |
1.4 | 34.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
1.4 | 15.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.4 | 31.5 | GO:0032156 | septin cytoskeleton(GO:0032156) |
1.3 | 39.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.3 | 28.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
1.3 | 9.4 | GO:0016589 | NURF complex(GO:0016589) |
1.3 | 50.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
1.3 | 17.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.3 | 13.2 | GO:0044292 | dendrite terminus(GO:0044292) |
1.2 | 34.9 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
1.2 | 26.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.2 | 3.6 | GO:0001652 | granular component(GO:0001652) |
1.2 | 62.8 | GO:0031941 | filamentous actin(GO:0031941) |
1.2 | 174.0 | GO:0015934 | large ribosomal subunit(GO:0015934) |
1.2 | 3.5 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
1.1 | 26.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
1.1 | 7.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.1 | 3.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.1 | 11.1 | GO:0070187 | telosome(GO:0070187) |
1.1 | 3.3 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
1.1 | 8.8 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
1.1 | 12.0 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
1.1 | 3.2 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
1.0 | 9.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
1.0 | 16.4 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
1.0 | 11.1 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
1.0 | 7.0 | GO:0031415 | NatA complex(GO:0031415) |
1.0 | 64.2 | GO:0035577 | azurophil granule membrane(GO:0035577) |
1.0 | 2.9 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.9 | 9.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.9 | 9.9 | GO:0005869 | dynactin complex(GO:0005869) |
0.9 | 7.1 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.9 | 12.3 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.8 | 165.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.8 | 4.9 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.8 | 4.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.8 | 3.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.8 | 4.9 | GO:0000124 | SAGA complex(GO:0000124) |
0.8 | 4.0 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.8 | 12.7 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.8 | 7.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.8 | 8.6 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.8 | 4.6 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.7 | 13.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.7 | 44.7 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.7 | 7.7 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.7 | 30.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.7 | 34.4 | GO:0043034 | costamere(GO:0043034) |
0.7 | 0.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.7 | 11.5 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.7 | 3.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.7 | 9.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.7 | 2.0 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.6 | 4.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.6 | 7.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.6 | 30.2 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.6 | 3.7 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.6 | 4.9 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.6 | 11.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.6 | 62.5 | GO:0005840 | ribosome(GO:0005840) |
0.6 | 1.8 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.6 | 14.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.6 | 9.3 | GO:0030686 | 90S preribosome(GO:0030686) |
0.6 | 4.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.6 | 15.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.6 | 6.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.6 | 3.4 | GO:0042825 | TAP complex(GO:0042825) |
0.6 | 63.8 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.6 | 2.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.6 | 3.3 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.6 | 6.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.5 | 1.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.5 | 4.7 | GO:0061574 | ASAP complex(GO:0061574) |
0.5 | 1.0 | GO:0033011 | perinuclear theca(GO:0033011) cytoskeletal calyx(GO:0033150) |
0.5 | 3.5 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.5 | 13.6 | GO:0035861 | site of double-strand break(GO:0035861) |
0.5 | 2.0 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.5 | 13.0 | GO:0098553 | integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.5 | 41.7 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.5 | 5.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.4 | 9.4 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.4 | 48.3 | GO:0016605 | PML body(GO:0016605) |
0.4 | 28.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.4 | 2.1 | GO:0034464 | BBSome(GO:0034464) |
0.4 | 27.0 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.4 | 32.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.4 | 30.2 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.4 | 2.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.4 | 4.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.4 | 3.3 | GO:0032059 | bleb(GO:0032059) |
0.4 | 4.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 6.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 4.9 | GO:0071437 | invadopodium(GO:0071437) |
0.3 | 8.0 | GO:0016234 | inclusion body(GO:0016234) |
0.3 | 3.3 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.3 | 7.9 | GO:0032420 | stereocilium(GO:0032420) |
0.3 | 8.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 1.3 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.3 | 24.2 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.3 | 4.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.3 | 10.2 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.3 | 8.9 | GO:0072686 | mitotic spindle(GO:0072686) |
0.3 | 28.0 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.3 | 10.9 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.3 | 25.5 | GO:0005643 | nuclear pore(GO:0005643) |
0.3 | 1.7 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
0.3 | 6.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.3 | 3.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 1.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 4.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.3 | 3.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 2.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.2 | 0.9 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
0.2 | 0.7 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 12.2 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.2 | 17.5 | GO:0031902 | late endosome membrane(GO:0031902) |
0.2 | 61.5 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 0.8 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 1.7 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 0.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 14.2 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.2 | 2.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 15.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 1.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 1.4 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.2 | 0.4 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.2 | 6.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 0.7 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 1.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 7.8 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.7 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 14.1 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 7.0 | GO:0005635 | nuclear envelope(GO:0005635) |
0.1 | 4.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 1.0 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 1.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 2.0 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 5.9 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 33.8 | GO:1990904 | ribonucleoprotein complex(GO:1990904) |
0.1 | 0.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 1.6 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.4 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 22.1 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 2.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 1.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 1.2 | GO:0005740 | mitochondrial envelope(GO:0005740) |
0.1 | 1.4 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.1 | 6.4 | GO:0005903 | brush border(GO:0005903) |
0.1 | 4.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 8.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 4.5 | GO:0005814 | centriole(GO:0005814) |
0.1 | 13.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 2.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 1.8 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 1.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.8 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 0.1 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.0 | 19.9 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.8 | GO:0000791 | euchromatin(GO:0000791) nuclear euchromatin(GO:0005719) |
0.0 | 2.0 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 2.6 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.8 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.5 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.9 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 5.3 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 1.6 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.4 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.7 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.4 | 43.3 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
13.8 | 41.4 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
13.6 | 54.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
12.0 | 36.0 | GO:0000035 | acyl binding(GO:0000035) phosphopantetheine binding(GO:0031177) |
11.6 | 69.7 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
10.6 | 31.7 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
10.1 | 40.3 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
8.9 | 26.7 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
8.3 | 33.3 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
7.8 | 23.5 | GO:0070362 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
7.0 | 7.0 | GO:0032427 | GBD domain binding(GO:0032427) |
6.5 | 19.5 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
6.5 | 26.0 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
5.8 | 76.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
5.7 | 28.4 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
5.5 | 38.3 | GO:0004459 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
5.2 | 31.5 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
5.1 | 20.5 | GO:0043515 | kinetochore binding(GO:0043515) |
5.0 | 20.0 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
4.9 | 4.9 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
4.7 | 28.4 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
4.7 | 14.2 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
4.5 | 13.5 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
4.4 | 70.0 | GO:0031996 | thioesterase binding(GO:0031996) |
4.4 | 95.8 | GO:0000339 | RNA cap binding(GO:0000339) |
4.3 | 12.8 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
4.3 | 25.5 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
4.2 | 12.5 | GO:0002134 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) sulfonylurea receptor binding(GO:0017098) pyrimidine ribonucleoside binding(GO:0032551) |
4.1 | 12.3 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
4.1 | 28.5 | GO:0004793 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
3.9 | 27.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
3.5 | 13.9 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
3.4 | 125.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
3.4 | 33.7 | GO:0019237 | centromeric DNA binding(GO:0019237) |
3.2 | 25.5 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
3.2 | 9.5 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
3.1 | 63.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
3.1 | 12.3 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
3.1 | 9.2 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
3.0 | 27.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
3.0 | 33.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
3.0 | 77.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
2.9 | 8.7 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
2.9 | 52.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
2.9 | 14.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
2.9 | 23.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
2.8 | 31.3 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
2.8 | 8.5 | GO:0098770 | FBXO family protein binding(GO:0098770) |
2.8 | 16.9 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
2.8 | 8.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
2.7 | 13.7 | GO:0002046 | opsin binding(GO:0002046) |
2.7 | 15.9 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
2.6 | 15.7 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
2.6 | 77.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
2.6 | 10.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
2.5 | 17.7 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
2.5 | 14.9 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
2.5 | 17.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
2.5 | 19.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
2.4 | 7.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
2.4 | 14.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
2.4 | 16.9 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
2.4 | 40.8 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
2.4 | 35.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
2.3 | 51.3 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
2.3 | 13.5 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
2.2 | 8.9 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
2.2 | 6.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
2.2 | 28.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
2.2 | 6.5 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
2.1 | 15.0 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
2.1 | 21.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
2.1 | 4.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
2.1 | 31.2 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
2.1 | 20.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
2.0 | 6.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
2.0 | 19.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
1.9 | 13.6 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.9 | 15.5 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
1.9 | 7.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
1.8 | 18.1 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
1.8 | 10.7 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.8 | 7.1 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
1.7 | 5.2 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
1.7 | 10.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
1.7 | 13.6 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
1.7 | 77.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
1.7 | 11.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
1.6 | 9.9 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
1.6 | 4.9 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
1.6 | 4.9 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
1.6 | 70.1 | GO:0050699 | WW domain binding(GO:0050699) |
1.6 | 8.0 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.6 | 61.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
1.6 | 9.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.6 | 65.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
1.5 | 9.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
1.5 | 15.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
1.5 | 25.6 | GO:0070513 | death domain binding(GO:0070513) |
1.5 | 23.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.5 | 23.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
1.4 | 88.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
1.4 | 7.1 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
1.4 | 19.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
1.4 | 8.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.3 | 6.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
1.3 | 2.6 | GO:0004998 | transferrin receptor activity(GO:0004998) |
1.3 | 6.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
1.3 | 18.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.3 | 38.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
1.3 | 1.3 | GO:0048039 | ubiquinone binding(GO:0048039) |
1.2 | 12.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
1.2 | 19.9 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
1.2 | 4.9 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
1.2 | 8.5 | GO:0030911 | TPR domain binding(GO:0030911) |
1.2 | 7.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
1.2 | 9.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
1.2 | 20.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
1.2 | 4.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.1 | 19.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.1 | 10.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
1.1 | 4.4 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.1 | 16.6 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
1.1 | 7.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.1 | 6.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.1 | 32.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
1.1 | 4.3 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
1.1 | 18.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
1.1 | 21.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.1 | 3.2 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
1.1 | 68.8 | GO:0035064 | methylated histone binding(GO:0035064) |
1.1 | 11.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
1.0 | 8.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.0 | 5.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
1.0 | 15.5 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
1.0 | 3.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
1.0 | 3.0 | GO:0034046 | poly(G) binding(GO:0034046) |
1.0 | 52.7 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
1.0 | 20.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.0 | 2.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
1.0 | 2.9 | GO:0070699 | type II activin receptor binding(GO:0070699) |
1.0 | 11.5 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.9 | 32.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.9 | 3.7 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.9 | 9.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.9 | 3.7 | GO:0052794 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.9 | 12.0 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.9 | 2.7 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
0.9 | 36.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.9 | 8.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.8 | 3.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.8 | 2.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.8 | 11.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.8 | 8.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.8 | 54.0 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.8 | 175.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.8 | 7.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.8 | 4.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.8 | 4.0 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.8 | 8.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.8 | 8.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.8 | 2.4 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.8 | 1.6 | GO:0030984 | kininogen binding(GO:0030984) |
0.8 | 30.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.8 | 4.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.8 | 6.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.8 | 21.0 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.8 | 14.7 | GO:0048156 | tau protein binding(GO:0048156) |
0.7 | 2.2 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
0.7 | 29.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.7 | 5.8 | GO:0034594 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.7 | 5.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.7 | 12.8 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.7 | 7.7 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.7 | 4.9 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.7 | 30.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.7 | 12.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.7 | 2.0 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.7 | 8.5 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.7 | 25.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.7 | 28.7 | GO:0000049 | tRNA binding(GO:0000049) |
0.6 | 9.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.6 | 3.9 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.6 | 1.9 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.6 | 22.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.6 | 13.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.6 | 4.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.6 | 17.2 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.6 | 5.5 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.6 | 3.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.6 | 20.5 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.6 | 7.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.6 | 3.4 | GO:0023029 | MHC class Ib protein binding(GO:0023029) TAP2 binding(GO:0046979) |
0.6 | 1.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.6 | 5.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.5 | 1.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.5 | 2.7 | GO:0034597 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.5 | 2.2 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.5 | 5.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.5 | 18.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.5 | 7.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.5 | 1.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.5 | 3.2 | GO:0039552 | RIG-I binding(GO:0039552) |
0.5 | 4.7 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.5 | 6.3 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.5 | 8.1 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.5 | 1.5 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.5 | 7.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.5 | 3.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.5 | 1.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.5 | 3.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.5 | 35.0 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.5 | 5.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.5 | 1.9 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.5 | 6.0 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.5 | 24.2 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.5 | 7.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.5 | 17.6 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.4 | 7.6 | GO:0070402 | NADPH binding(GO:0070402) |
0.4 | 5.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.4 | 45.3 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.4 | 4.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.4 | 11.5 | GO:0043531 | ADP binding(GO:0043531) |
0.4 | 29.8 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.4 | 4.6 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.4 | 3.8 | GO:0051400 | BH domain binding(GO:0051400) |
0.4 | 6.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 3.6 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.4 | 7.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.4 | 4.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.4 | 5.8 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.4 | 8.9 | GO:0070840 | dynein complex binding(GO:0070840) |
0.4 | 1.5 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.4 | 13.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.4 | 13.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.4 | 2.6 | GO:0035173 | histone kinase activity(GO:0035173) |
0.4 | 22.1 | GO:0019003 | GDP binding(GO:0019003) |
0.4 | 3.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 2.1 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.4 | 14.8 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.3 | 4.7 | GO:0031491 | nucleosome binding(GO:0031491) |
0.3 | 7.4 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.3 | 3.4 | GO:0008201 | heparin binding(GO:0008201) |
0.3 | 17.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 51.9 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.3 | 3.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.3 | 8.2 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.3 | 1.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.3 | 3.5 | GO:0031386 | protein tag(GO:0031386) |
0.3 | 37.1 | GO:0044325 | ion channel binding(GO:0044325) |
0.3 | 6.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.3 | 3.5 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 5.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 4.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 23.2 | GO:0019905 | syntaxin binding(GO:0019905) |
0.3 | 9.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.3 | 20.8 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.3 | 4.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 3.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 1.8 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.3 | 4.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.3 | 7.8 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.3 | 1.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 2.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 2.9 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 2.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 0.9 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 2.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 2.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 3.7 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 0.7 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.2 | 12.9 | GO:0004386 | helicase activity(GO:0004386) |
0.2 | 18.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.2 | 5.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 3.4 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 0.6 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.2 | 2.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 2.7 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.2 | 1.9 | GO:0030882 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
0.2 | 0.9 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.2 | 5.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 214.0 | GO:0003723 | RNA binding(GO:0003723) |
0.2 | 2.0 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.2 | 6.5 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 4.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 0.5 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.2 | 2.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 2.4 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.2 | 2.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.2 | 8.6 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 1.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.2 | 3.4 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.2 | 1.4 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.2 | 35.9 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 1.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 1.8 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 1.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 6.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 1.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.4 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.1 | 1.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.9 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 1.3 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 6.5 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.1 | 0.8 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 3.0 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 0.7 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 2.4 | GO:0004872 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.1 | 0.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.8 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 1.0 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.1 | 1.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 1.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 1.1 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 3.1 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.2 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.1 | 3.8 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.1 | 3.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.7 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 3.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 1.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.0 | 1.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 2.2 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.3 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.0 | 1.7 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.8 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.4 | GO:0033558 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.0 | 0.5 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 2.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
2.0 | 82.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.8 | 165.5 | PID P53 REGULATION PATHWAY | p53 pathway |
1.3 | 80.8 | PID AURORA B PATHWAY | Aurora B signaling |
1.2 | 127.3 | PID E2F PATHWAY | E2F transcription factor network |
1.0 | 37.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
1.0 | 22.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.0 | 121.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
1.0 | 26.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.9 | 49.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.8 | 25.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.8 | 16.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.8 | 12.5 | ST STAT3 PATHWAY | STAT3 Pathway |
0.7 | 19.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.7 | 36.7 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.7 | 6.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.7 | 9.5 | PID FOXO PATHWAY | FoxO family signaling |
0.7 | 8.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.7 | 18.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.6 | 12.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.6 | 23.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.6 | 18.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.6 | 34.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.6 | 13.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.5 | 16.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.5 | 14.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.5 | 22.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.5 | 11.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.5 | 26.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.5 | 30.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.5 | 71.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.5 | 40.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.5 | 7.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 7.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.4 | 15.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.4 | 10.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 3.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.4 | 12.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.4 | 12.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 6.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 3.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 4.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 4.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 12.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 4.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 6.6 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 12.0 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 1.9 | PID ATM PATHWAY | ATM pathway |
0.2 | 4.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 4.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 2.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 1.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 4.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 2.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 2.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 5.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 3.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 3.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 2.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 1.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 2.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 1.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 2.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 130.5 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
3.2 | 51.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
2.8 | 50.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
2.3 | 59.8 | REACTOME KINESINS | Genes involved in Kinesins |
2.2 | 53.6 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
2.1 | 70.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
2.1 | 72.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
2.1 | 34.9 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
1.9 | 53.9 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
1.9 | 47.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
1.9 | 143.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
1.9 | 40.8 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.8 | 38.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
1.8 | 42.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
1.8 | 45.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.8 | 36.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
1.8 | 18.0 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
1.8 | 39.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
1.7 | 15.7 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
1.7 | 32.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.7 | 40.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.6 | 64.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
1.6 | 44.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.6 | 48.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.5 | 118.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
1.5 | 33.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
1.4 | 20.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
1.4 | 22.9 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
1.4 | 46.5 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
1.4 | 49.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.3 | 7.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.3 | 8.9 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
1.2 | 32.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.2 | 38.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
1.2 | 19.5 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
1.2 | 46.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.2 | 20.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
1.1 | 26.8 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
1.1 | 28.6 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
1.0 | 70.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.0 | 9.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
1.0 | 36.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.9 | 23.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.9 | 4.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.9 | 28.8 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.9 | 17.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.9 | 10.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.9 | 7.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.9 | 29.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.9 | 28.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.9 | 15.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.9 | 10.2 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.9 | 70.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.8 | 26.1 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.8 | 26.2 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.8 | 93.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.8 | 23.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.8 | 9.8 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.7 | 19.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.7 | 17.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.7 | 123.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.7 | 2.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.7 | 8.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.6 | 28.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.6 | 7.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.6 | 22.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.6 | 50.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.6 | 30.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.6 | 29.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.6 | 22.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.6 | 4.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.6 | 35.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.6 | 3.6 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.6 | 17.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.6 | 6.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.6 | 1.7 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.5 | 4.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.5 | 34.7 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.5 | 16.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.5 | 11.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.5 | 1.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 6.0 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.4 | 39.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.4 | 4.3 | REACTOME OPSINS | Genes involved in Opsins |
0.4 | 3.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.4 | 5.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.3 | 20.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 8.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 7.6 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 7.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 10.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.3 | 3.2 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.3 | 1.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 7.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 2.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 6.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 3.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 11.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 3.9 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 34.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 7.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 20.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 1.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 1.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 2.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 10.1 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.2 | 1.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 4.3 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.2 | 3.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 5.8 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 8.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 2.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 2.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 3.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.2 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.1 | 1.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 4.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 5.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 2.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.3 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 2.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 1.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |